Diabetes Care

Metformin IR, SR and PR Tablets and What Their Labels Mean

Understand release forms, everyday tablet questions, treatment reviews and the checks that help keep metformin use safe.

By Global Medicines ExportUpdated: Educational article

Formulation reference

Reading metformin release wording

Match the release description to the exact brand leaflet and prescription.

Tablet identity and practical checks

Label wordingWhat it identifiesWhat to confirm
IR or ordinary tabletImmediate-release presentationMeal timing and the prescribed tablet schedule
SR, ER or XRModified-release wording used by the manufacturerExact formulation, whole-tablet handling and timing
PR or prolonged-releaseProlonged-release wordingThe named product instructions and prescribed strength
Combination tabletMetformin plus another active ingredientEvery ingredient, strength and additional precaution

Selected UK adult prolonged-release dose references

FeatureBrown & Burk 500 mg prolonged-release label
ScopeType 2 diabetes in adults with normal renal function, GFR at least 90 mL/min
Usual starting amount500 mg once daily
Adjustment described500 mg increments every 10 to 15 days according to blood glucose
Usual once-daily limit described2,000 mg with the evening meal

The numerical table summarises selected instructions for the named UK product and population. Its full label also describes further prescriber-managed options when control is inadequate. Other formulations, kidney-function categories and supplied brands require their own instructions.

What does metformin do in type 2 diabetes?

In type 2 diabetes, the body has difficulty using insulin effectively, and insulin production can become insufficient. Metformin reduces the liver's glucose output and improves insulin sensitivity, helping glucose move into tissues. It can be prescribed alone or with other treatments.

This guide covers adult type 2 diabetes and identifies UK and US reference products. Use your own brand leaflet alongside the eating, activity and follow-up plan agreed with your diabetes team.

How do IR, SR, ER and PR tablets differ?

Immediate-release tablets release medicine without a prolonged-release mechanism. SR, ER, XR and PR are release descriptions used on modified-release products. The manufacturer's full wording matters because timing and handling belong to the specific formulation.

GME's catalogue includes Glycomet-250, Biciphage sustained-release presentations and Maxformin prolonged-release tablets. A 250 mg strength describes one tablet. A 500-tablet pack describes quantity. When a prescription changes, have the pharmacist confirm the formulation, tablet count and total prescribed amount together.

How soon can you judge whether treatment is helping?

A fasting glucose test measures the level at that blood draw. HbA1c reflects average glucose over roughly three months, with more recent levels contributing to the result. Feeling unchanged after starting treatment does not show whether glucose control has improved.

UK NICE guidance recommends HbA1c checks every three to six months, tailored to need, until stable on unchanged treatment. Earlier glucose checks may serve a different purpose. Record results with dates and the current prescription. HbA1c vs Fasting Blood Sugar explains these measurements in more detail.

How should tablets be taken with food?

NHS advice places metformin with food. The cited Brown & Burk prolonged-release product describes evening-meal administration. Check the actual packet for your timing, especially when moving between immediate- and modified-release products.

Swallow tablets as the leaflet directs. The cited US extended-release label says to keep tablets whole, without cutting, crushing or chewing. If swallowing is difficult, ask about a suitable formulation. The UK Brown & Burk label explains that an empty tablet shell can appear in stool. Follow its advice rather than taking an extra dose.

Why are doses adjusted gradually, and what if one is missed?

A gradual increase lets the prescriber assess glucose response and digestive tolerance. Changes depend on the product and kidney function. A higher-strength pack provides a different amount per tablet and should be matched to the written plan.

The selected numerical references above come from the current UK Brown & Burk 500 mg prolonged-release label for adults with type 2 diabetes and normal renal function. They illustrate how a named label describes gradual adjustment. They do not establish an individual schedule for the Glycomet, Biciphage or Maxformin listings, and the prescriber must account for the exact formulation and kidney function.

Missed-dose instructions need the supplied leaflet. For the cited US extended-release product, take the next dose on its normal schedule and avoid taking two doses that day to replace the omission. NHS general advice differs according to the dosing pattern and how near the next dose is. Ask a pharmacist if those instructions are unclear.

What helps with nausea, diarrhoea or stomach discomfort?

Nausea, diarrhoea, abdominal discomfort and reduced appetite can occur, particularly when treatment begins. Taking tablets with the prescribed meal and following gradual adjustment may improve tolerance. Discuss persistent symptoms with the pharmacist or prescriber, who can reassess the product and plan.

Keep a record of symptoms, meals and recent changes. Severe or repeated vomiting or diarrhoea, difficulty drinking, reduced urination or marked weakness needs prompt advice because dehydration changes the risk. Unusual breathing difficulty, severe exhaustion or abdominal pain can signal a serious problem. Suspected lactic acidosis requires stopping metformin and emergency assessment.

When should vitamin B12 be checked?

Metformin can lower vitamin B12. MHRA identifies higher doses, longer use and existing deficiency risks as reasons for closer attention. New tingling, numbness, unusual fatigue, a sore tongue or anaemia symptoms deserve assessment because diabetes and other conditions can cause similar problems.

The regulator advises testing when deficiency is suspected and considering periodic checks for people with risk factors. Its advice allows metformin to continue while deficiency is corrected when treatment remains suitable. Metformin and Vitamin B12 covers testing questions and what to bring to a review.

How does kidney function affect treatment?

The kidneys clear metformin, so impaired function can allow accumulation. The cited US extended-release label requires kidney assessment before treatment and during follow-up. It contraindicates treatment below an eGFR of 30 mL/min/1.73 m² and advises against starting it between 30 and 45. Continuing treatment as function changes requires a benefit-risk review.

Bring recent results and their dates. Kidney disease varies in severity, and a new illness can cause a sudden change. The exact product and clinical circumstances determine the plan. eGFR and Urine ACR explains the blood and urine tests often discussed together.

What changes during illness, surgery or a contrast scan?

The UK Brown & Burk label advises temporarily withholding metformin during dehydration from severe vomiting, diarrhoea, fever or reduced fluid intake, and contacting a healthcare professional. Ask your team for an illness plan and restart instructions in advance.

Tell the team arranging surgery under general, spinal or epidural anaesthesia, or iodinated contrast imaging, that you take metformin. The UK Brown & Burk product requires at least 48 hours before restarting and reassessment showing stable kidney function. After surgery, oral nutrition must also have resumed. US contrast instructions identify particular risk groups. The procedural team should provide a written plan for the exact medicine and procedure.

Which medicines and alcohol need attention?

Give the pharmacist the full list, including painkillers and supplements. The UK label highlights NSAIDs, diuretics and some blood pressure medicines because kidney monitoring may be needed. The US label highlights medicines such as topiramate and cimetidine that can alter risk or metformin handling. Heavy alcohol intake increases lactic-acidosis risk.

Metformin alone has a low risk of hypoglycaemia. Insulin or medicines such as sulfonylureas change that risk and may need clinician-led adjustment. Ask how to recognise and respond to low readings. Dapagliflozin vs Empagliflozin explains two other medicines with their own treatment goals and precautions.

Matching a product and preparing an enquiry

For a product enquiry, provide the ingredient, strength, release form, manufacturer, pack quantity and destination. Combination tablets need every ingredient and strength recorded. Metformin 250 mg Tablets, Metformin 500 mg SR Tablets and Metformin 750 mg PR Tablets have separate catalogue listings. Request the leaflet for the offered presentation.

Export product support

Need product, pack, and documentation details?

Global Medicines Export can support international B2B enquiries for product availability, strengths, pack information, quotation coordination, and shipment documentation review.

Common questions

Can I exchange IR and SR using the same tablet count?

Have the pharmacist confirm the release form, strength and total daily amount. A change in formulation needs its own prescription instructions.

Should I double the next dose if I forget a tablet?

Avoid doubling to replace a missed dose. Follow your specific leaflet because the timing advice varies by product and dosing pattern.

Does diarrhoea mean I must abandon treatment?

Persistent symptoms need review. The prescriber may reassess tolerance and formulation. Severe diarrhoea or dehydration needs prompt illness advice.

Does an empty shell in stool mean the dose failed?

The Brown & Burk prolonged-release label describes shell passage as expected. Ask a pharmacist to check your actual product before drawing conclusions.

Can I use how I feel to judge my glucose control?

Use the agreed glucose tests and HbA1c review. Symptoms alone do not reliably describe control or determine a dose change.

Does every person taking metformin need B12 injections?

Symptoms, tests and the cause of any deficiency guide replacement. The MHRA recommends investigation and risk-based monitoring, with treatment tailored to findings.

Should I stop before every scan?

Tell the imaging team your medicine and kidney history. Iodinated contrast and particular procedures have specific holding and restart rules.

Can metformin be taken with another diabetes medicine?

It is sometimes prescribed in combinations. Each added medicine has its own benefits, interactions and monitoring needs, including its effect on hypoglycaemia risk.

Important medical note

This article is for general educational information only. It is not medical advice, diagnosis, or a treatment plan. Medicines should be used only under the guidance of a qualified healthcare professional. Product availability, export documentation, and quotation support do not imply that a medicine is appropriate for any individual patient.

References